Clement Goehrs

Clement Goehrs has a diverse work experience in the field of healthcare and technology. Clement is currently the Co-Founder & CEO of Synapse Medicine - Medication Intelligence since November 2017. Prior to that, they worked as a Visiting Research Scholar at Stanford University from October 2016 to May 2017, where their research focused on knowledge representation in pharmacology and artificial intelligence applied to prescription assistance. Clement was also the Leader & Co-Founder of Hacking Health Bdx, a non-profit organization, from April 2015 to January 2017. In addition, they have worked as a Resident Medical Officer at Bordeaux University Hospital and INSERM 1219 Computer research applied to health - ERIAS Team, where their work involved knowledge representation in pharmacology and the application of expert systems and artificial intelligence to healthcare. Clement was also involved in methodological consultation, writing research protocols, and statistical analysis during their time as a Medical Resident at the same institution. Furthermore, Clement served as the President of AISPB (Association of Public Health Resident Bordeaux) from November 2014 to November 2015. Prior to that, they worked as a Medical Resident at INSERM from November 2013 to May 2014. Overall, their work experience showcases their dedication to improving healthcare through innovative technologies and multidisciplinary collaborations.

Clement Goehrs began their education at Lycée Hoche, where they obtained their Baccalauréat in the field of Science in 2006. Clement then pursued a Doctor of Medicine (M.D.) degree at Université Paris-Saclay from 2006 to 2013. Following this, Goehrs enrolled at Université de Bordeaux and completed a Master of Public Health (MPH) degree, specializing in Public Health, from 2013 to 2017. In 2015, they also attended Institut de santé publique, d'épidémiologie et de développement (ISPED) and achieved a Master's degree in Biomedical Informatics. Lastly, in 2016, Goehrs attended Stanford University Graduate School of Business to participate in the General Management LEAD program for Corporate Innovation.